Concepedia

Lili Yang

LY

11

Publications

946

Citations

11

H-Index

2009

Active since

Affiliations

Takeda (United States)(Current)

Takeda (Japan)

Millennium Engineering and Integration (United States)

Lili Yang is an author at Takeda (United States) specializing in medicine, immunology, and inflammation.

ORCID

Top concepts

Publications per year

2009–2023

11

Publications

11

The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases

Dulce Soler, Tobias R. Chapman, Lili Yang et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 451 citations

Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates

Eric R. Fedyk, Tim Wyant, Lili Yang et al. · Inflammatory Bowel Diseases · 2012 · 138 citations · Full text

Tuberous sclerosis complex–mediated mTORC1 overactivation promotes age-related hearing loss

Xiaolong Fu, Xiaoyang Sun, Linqing Zhang et al. · Journal of Clinical Investigation · 2018 · 87 citations · Full text

, , +21

Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis

Krista G. Haanstra, Sam Hofman, Dave M. Lopes Estêvão et al. · The Journal of Immunology · 2013 · 79 citations · Full text

In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes

Tim Wyant, Lili Yang, Eric R. Fedyk · mAbs · 2013 · 58 citations · Full text

, , +24

Rows per page

1–5 of 11